# CNS10-NPC for the Treatment of RP

> **NCT04284293** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 16 (estimated)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **BIOLOGICAL:** CNS10-NPC implantation

## Key facts

- **NCT ID:** NCT04284293
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-22
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04284293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04284293, "CNS10-NPC for the Treatment of RP". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04284293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*